Literature DB >> 25260693

Changes in the basal membrane of dorsal root ganglia Schwann cells explain the biphasic pattern of the peripheral neuropathy in streptozotocin-induced diabetic rats.

Maria Becker1, Tali Benromano, Abraham Shahar, Zvi Nevo, Chaim G Pick.   

Abstract

Peripheral neuropathy is one of the main complications of diabetes mellitus. The current study demonstrated the bimodal pattern of diabetic peripheral neuropathy found in the behavioral study of pain perception in parallel to the histopathological findings in dorsal root ganglia (DRGs) neurons and satellite Schwann cell basement membranes. A gradual decrease in heparan sulfate content, with a reciprocal increase in deposited laminin in the basement membranes of dorsal root ganglia Schwann cells, was shown in streptozotocin-treated rats. In addition, the characteristic biphasic pain profiles were demonstrated in diabetic rats, as shown by hypersensitivity at the third week and hyposensitivity at the tenth week post-streptozotocin injection, accompanied by a continuous decrease in the sciatic nerve conduction velocity. It appears that these basal membrane abnormalities in content of heparan sulfate and laminin, noticed in diabetic rats, may underline the primary damage in dorsal ganglion sensory neurons, simultaneously with the bimodal painful profile in diabetic peripheral neuropathy, simulating the scenario of filtration rate in diabetic kidney.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25260693     DOI: 10.1007/s12031-014-0424-2

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  51 in total

1.  The extracellular matrix of peripheral nerve in diabetic polyneuropathy.

Authors:  J L Bradley; R H King; J R Muddle; P K Thomas
Journal:  Acta Neuropathol       Date:  2000-05       Impact factor: 17.088

2.  Inhibition of type 1 diabetic hyperalgesia in streptozotocin-induced Wistar versus spontaneous gene-prone BB/Worchester rats: efficacy of a selective bradykinin B1 receptor antagonist.

Authors:  Bichoy H Gabra; Ouhida Benrezzak; Leng-Hong Pheng; Dana Duta; Philippe Daull; Pierre Sirois; François Nantel; Bruno Battistini
Journal:  J Neuropathol Exp Neurol       Date:  2005-09       Impact factor: 3.685

3.  Nonviral gene transfer of human hepatocyte growth factor improves streptozotocin-induced diabetic neuropathy in rats.

Authors:  Naoki Kato; Koichi Nemoto; Kuniaki Nakanishi; Ryuichi Morishita; Yasufumi Kaneda; Maki Uenoyama; Tomosumi Ikeda; Kyosuke Fujikawa
Journal:  Diabetes       Date:  2005-03       Impact factor: 9.461

4.  Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats.

Authors:  Fei Li; Irina G Obrosova; Omorodola Abatan; Dequan Tian; Dennis Larkin; Edward L Stuenkel; Martin J Stevens
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-01       Impact factor: 4.310

5.  Morphometry of dorsal root ganglion in chronic experimental diabetic neuropathy.

Authors:  Motoko Kishi; James Tanabe; James D Schmelzer; Phillip A Low
Journal:  Diabetes       Date:  2002-03       Impact factor: 9.461

6.  Advanced glycation end-products disrupt the blood-brain barrier by stimulating the release of transforming growth factor-β by pericytes and vascular endothelial growth factor and matrix metalloproteinase-2 by endothelial cells in vitro.

Authors:  Fumitaka Shimizu; Yasuteru Sano; Osamu Tominaga; Toshihiko Maeda; Masa-aki Abe; Takashi Kanda
Journal:  Neurobiol Aging       Date:  2013-02-19       Impact factor: 4.673

7.  A method for unbiased and efficient estimation of number and mean volume of specified neuron subtypes in rat dorsal root ganglion.

Authors:  T Tandrup
Journal:  J Comp Neurol       Date:  1993-03-08       Impact factor: 3.215

8.  Maffucci's syndrome--the result of neural abnormalities? Evidence of mitogenic neurotransmitters present in enchondromas and soft tissue hemangiomas.

Authors:  D Robinson; M Tieder; N Halperin; D Burshtein; Z Nevo
Journal:  Cancer       Date:  1994-08-01       Impact factor: 6.860

9.  Heparan sulfate proteoglycans are lost in patients with diabetic nephropathy.

Authors:  H Makino; S Ikeda; T Haramoto; Z Ota
Journal:  Nephron       Date:  1992       Impact factor: 2.847

10.  Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes.

Authors:  Beatriz Duran-Jimenez; Darin Dobler; Sarah Moffatt; Naila Rabbani; Charles H Streuli; Paul J Thornalley; David R Tomlinson; Natalie J Gardiner
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

View more
  5 in total

Review 1.  Schwann cell interactions with axons and microvessels in diabetic neuropathy.

Authors:  Nádia P Gonçalves; Christian B Vægter; Henning Andersen; Leif Østergaard; Nigel A Calcutt; Troels S Jensen
Journal:  Nat Rev Neurol       Date:  2017-01-30       Impact factor: 42.937

2.  The effect of spinally administered WIN 55,212-2, a cannabinoid agonist, on thermal pain sensitivity in diabetic rats.

Authors:  Samane Jahanabadi; Mohamad Reza Hadian; Javad Shamsaee; Seyed Mohammad Tavangar; Alireza Abdollahi; Ahmadreza Dehpour; Shahram Ejtemaei Mehr
Journal:  Iran J Basic Med Sci       Date:  2016-04       Impact factor: 2.699

3.  Cortex Mori Radicis extract promotes neurite outgrowth in diabetic rats by activating PI3K/AKT signaling and inhibiting Ca2+ influx associated with the upregulation of transient receptor potential canonical channel 1.

Authors:  Min Lu; Tao Yi; Yong Xiong; Qian Wang; Nina Yin
Journal:  Mol Med Rep       Date:  2019-11-21       Impact factor: 2.952

Review 4.  New Advances on Pathophysiology of Diabetes Neuropathy and Pain Management: Potential Role of Melatonin and DPP-4 Inhibitors.

Authors:  Prabhakar Busa; Yaswanth Kuthati; Niancih Huang; Chih-Shung Wong
Journal:  Front Pharmacol       Date:  2022-04-12       Impact factor: 5.988

5.  The Relationship between Dyslipidemia and Acute Axonal Function in Type 2 Diabetes Mellitus In Vivo.

Authors:  Natalie C G Kwai; William Nigole; Ann M Poynten; Christopher Brown; Arun V Krishnan
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.